How has the Indiana Genomics (INGEN) Initiative figured into proteomic research in Bloomington?
A. The foundation of the Proteomics Research and Development Facility was primarily enabled through a portion of funds from INGEN that were directed to the Bloomington campus. The INGEN-originated funds are supporting a purchase of major pieces of equipment for proteomics measurements as well as research activities. Basically, our mission is (a) to enhance collaboration with biomedical scientists at the IU School of Medicine and Bloomington science departments in the use of research proteomics; and (b) to develop new types of equipment for future investigations in the field. Q. What are your collaborative efforts now? A. Our efforts now range from working on bacterial and fruit fly proteomes with the biology faculty to animal models of alcohol dependency and diabetes, cancer cells and human samples with the School of Medicine faculty. Q. Can you tell us more about proteomics, which I understand is a relatively new term? A. The more recent developments in recombinant DNA technologies an
